A phase I study evaluating COM701 in patients with advanced solid tumors.

被引：0
|
作者：
Rasco, Drew W.
Vaena, Daniel A.
Sullivan, Ryan J.
Luke, Jason J.
ElNaggar, Adam
Hunter, John
Adewoye, Adeboye H.
Olweny, Judy
Patnaik, Amita
Hamilton, Erika Paige
机构：
[1] START, San Antonio, TX USA
[2] West Canc Ctr, Memphis, TN USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
[5] Compugen USA Inc, San Francisco, CA USA
[6] Tennessee Oncol PLLC, Nashville, TN USA
[7] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS2657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2657
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [2] A phase I study evaluating COM701 monotherapy and in combination with nivolumab in patients with advanced solid malignancies
    Sullivan, Ryan J.
    Lim, Emerson A.
    Sharma, Manish
    Shepard, Dale Randall
    Patnaik, Amita
    Hamilton, Erika Paige
    Fleming, Gini F.
    Papadopoulos, Kyriakos P.
    ElNaggar, Adam
    Adewoye, Adeboye H.
    Hunter, John
    Dumbrava, Ecaterina Elena Ileana
    Chmielowski, Bartosz
    Rasco, Drew W.
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [3] Phase I study of COM701 (a novel checkpoint inhibitor of PVRIG) in patients with advanced solid tumors
    Vaena, Dan
    Patnaik, Amita
    Hamilton, Erika
    Olweny, Judy
    Hunter, John
    Adewoye, Adeboye Henry
    ElNaggar, Adam
    Rasco, Drew
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Phase 1 study of COM701 monotherapy and in combination with nivolumab in patients with advanced solid tumors
    Dumbrava, Ecaterina
    Fleming, Gini
    Hamilton, Erika
    Sullivan, Ryan
    Patnaik, Amita
    Papadopoulos, Kyriakos
    ElNaggar, Adam
    Hunter, John
    Olweny, Judy
    Adewoye, Adewoye
    Chmielowski, Bartosz
    Shepard, Dale
    Sharma, Manish
    Lim, Emerson
    Vaena, Daniel
    Rasco, Drew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [5] COM701 (A NOVEL IMMUNE CHECKPOINT INHIBITOR) IN PATIENTS WITH ADVANCED SOLID TUMORS
    Elnaggar, A.
    Luke, J.
    Hamilton, E.
    Chmielowski, B.
    Ileana-Dumbrava, E.
    Patnaik, A.
    Lim, E.
    Adewoye, A.
    Hunter, J.
    Olweny, J.
    Sharma, M.
    Sullivan, R.
    Vaena, D.
    Rasco, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A161 - A161
  • [6] Phase 1 study of the safety, tolerability and preliminary anti-tumor activity of COM701 monotherapy in patients with advanced solid tumors
    Dumbrava, Ecaterina
    Fleming, Gini
    Hamilton, Erika
    Sullivan, Ryan
    Patnaik, Amita
    Papadopoulos, Kyriakos
    ElNaggar, Adam
    Hunter, John
    Olweny, Judy
    Adewoye, Adeboye
    Chmielowski, Bartosz
    Shepard, Dale
    Sharma, Manish
    Lim, Emerson
    Vaena, Daniel
    Rasco, Drew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] COM701 demonstrates preliminary antitumor activity as monotherapy and in combination with nivolumab in patients with advanced solid tumors
    Sullivan, Ryan
    Rasco, Drew
    Lim, Emerson
    Sharma, Manish
    Shepard, Dale
    Patnaik, Amita
    Hamilton, Erika
    Fleming, Gini
    Papadopoulos, Kyri
    ElNaggar, Adam
    Adewoye, Adeboye Henry
    Chmielowski, Bartosz
    Dumbrava, Ecaterina
    Vaena, Dan
    CANCER RESEARCH, 2020, 80 (16)
  • [8] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [10] A phase I open label study evaluating VT1021 in patients with advanced solid tumors.
    Cieslewicz, Michael
    Mahalingam, Devalingam
    Harb, Wael A.
    Patnaik, Amita
    Liu, Joyce F.
    Juric, Dejan
    Bullock, Andrea J.
    Zheng, Lei
    Moore, Kathleen N.
    Patel, Manish R.
    Guttendorf, Robert
    Wang, Suming
    Kerstein, Kathy
    Berk, Gregory Ivan
    Watnick, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345